Wang X, Liu LL, Li Q et al (2023) Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement. Histopathology 83:798–809. https://doi.org/10.1111/his.15024

Article  PubMed  Google Scholar 

Gawriyski L, Jouhilahti E, Yoshihara M et al (2023) Comprehensive characterization of the embryonic factor LEUTX. iscience. 26:106172. https://doi.org/10.1016/j.isci.2023.106172

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dermawan JK, Azzato EM, Mckenney JK et al (2021) YAP1-TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity. Histopathology 79:940–946. https://doi.org/10.1111/his.14437

Article  PubMed  Google Scholar 

Patton A, Bridge JA, Liebner D et al (2022) A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: a novel entity! Genes Chromosom Cancer 61:194–199. https://doi.org/10.1002/gcc.23018

Article  CAS  PubMed  Google Scholar 

Perret R, Tallegas M, Velasco V et al (2022) Recurrent YAP1::MAML2 fusions in “nodular necrotizing” variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases. Mod Pathol 35:1398–1404. https://doi.org/10.1038/s41379-022-01096-6

Article  CAS  PubMed  Google Scholar 

Dermawan JK, Dinapoli SE, Sukhadia P et al (2023) Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: a clinicopathologic study of seven cases demonstrating a heterogenous entity. Genes Chromosomes Cancer 62:191–201. https://doi.org/10.1002/gcc.23102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szulzewsky F, Holland EC, Vasioukhin V (2021) YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev Biol 475:205–221. https://doi.org/10.1016/j.ydbio.2020.12.018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szulzewsky F, Arora S, Hoellerbauer P et al (2020) Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis. Genes Dev 34:1051–1064. https://doi.org/10.1101/gad.338681.120

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barresi S, Giovannoni I, Rossi S et al (2021) A novel BRD4-LEUTX fusion in a pediatric sarcoma with epithelioid morphology and diffuse S100 expression. Genes Chromosom Cancer 60:647–652. https://doi.org/10.1002/gcc.22974

Article  CAS  PubMed  Google Scholar 

Andreiuolo F, Ferrone CK, Rajan S, et al (2024) Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion. Acta Neuropathologica Communications 12:42. https://doi.org/10.1186/s40478-024-01746-7

Song K, Huang Y, Xia CD et al (2022) A case of CIC-rearranged sarcoma with CIC-LEUTX gene fusion in spinal cord. Neuropathology 2022(42):555–562. https://doi.org/10.1111/neup.12850

Article  CAS  Google Scholar 

Linos K, Dermawan JK, Bale T et al (2023) Expanding the molecular diversity of CIC-rearranged sarcomas with novel and very rare partners. Mod Pathol 36:100103. https://doi.org/10.1016/j.modpat.2023.100103

Article  PubMed  PubMed Central  Google Scholar 

Huang SC, Zhang L, Sung YS et al (2016) Recurrent CIC gene abnormalities in angiosarcomas: a molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations. Am J Surg Pathol 40:645–655. https://doi.org/10.1097/PAS.0000000000000582

Article  PubMed  PubMed Central  Google Scholar 

Hu W, Wang J, Yuan L et al (2020) Case report: a unique case of pediatric central nervous system embryonal tumor harboring the CIC-LEUTX fusion, germline NBN variant and somatic TSC2 mutation: expanding the spectrum of CIC-rearranged neoplasia. Front Oncol 10:598970. https://doi.org/10.3389/fonc.2020.598970

Article  PubMed  PubMed Central  Google Scholar 

Lake JA, Donson AM, Prince E et al (2020) Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors. Pediatr Blood Cancer 67:e28028. https://doi.org/10.1002/pbc.28028

Article  CAS  PubMed  Google Scholar 

Sievers P, Sill M, Schrimpf D et al (2023) Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature. NPJ Precs Oncol 7:30. https://doi.org/10.1038/s41698-023-00372-1

Article  CAS  Google Scholar 

Decock A, Creytens D, Lefever S, et al (2022) mRNA capture sequencing and RT-qPCR for the detection of pathognomonic, novel, and secondary fusion transcripts in FFPE tissue: a sarcoma showcase. Int J Mol Sci 23:11007. https://doi.org/10.3390/ijms231911007

Lebrun L, Allard-Demoustiez S, Gilis N, et al (2023) Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as “CNS embryonal tumor with BRD4–LEUTX fusion”. Acta Neuropathol Commun 11:46. https://doi.org/10.1186/s40478-023-01549-2

Furtado LV, Santiago T, Shi Z et al (2023) Novel HNRNPM::LEUTX fusion resulting from chromothripsis of chromosome 19 in a pediatric undifferentiated small round cell neoplasm. Genes Chromosomes Cancer 62:740–745. https://doi.org/10.1002/gcc.23187

Article  CAS  PubMed  Google Scholar 

Panagopoulos I, Andersen K, Ramslien LF et al (2021) Therapy-related myeloid leukemia with the translocation t(8;19)(p11;q13) leading to a KAT6A-LEUTX fusion gene. Anticancer Res 41:1753–1760. https://doi.org/10.21873/anticanres.14940

Article  CAS  PubMed  Google Scholar